## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `article_bundle` — **LLM article bundle** Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. - **article slug:** `vip-chemo-neuropathy` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system. - **read:** https://miscsubjects.com/api/articles/vip-chemo-neuropathy/bundle?format=markdown ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/vip-chemo-neuropathy/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/vip-chemo-neuropathy/topology - **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/vip-chemo-neuropathy/voxels - **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/vip-chemo-neuropathy/prompts - **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node. - **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/vip-chemo-neuropathy/voxels - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.* --- # miscsubjects article bundle > Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest. ## MASTHEAD - **identity:** `vip-chemo-neuropathy` v2 · content_hash `3b78997c58af479f…` · thread_head genesis · 21 DIVs - **thesis (c1):** No human trials exist testing VIP for CIPN. - c3 [human/active] ASCO guidelines do not recommend gabapentin/pregabalin for CIPN prevention or treatment outside trials. - c2 [preclinical/active] In rat sciatic nerve injury models VIP supports remyelination and reduces Schwann cell inflammatory cytokines. - **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes - **standing objections:** 0 open → https://miscsubjects.com/api/articles/vip-chemo-neuropathy/discourse - **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key - **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/vip-chemo-neuropathy/discourse · https://miscsubjects.com/api/protocol ## Article - **slug:** `vip-chemo-neuropathy` - **title:** VIP for Chemotherapy-Induced Neuropathy: A Data-First Evidence Review - **url:** https://miscsubjects.com/a/vip-chemo-neuropathy - **register:** source_ledger - **updated:** 2026-07-17T02:43:22.642Z - **tags:** peptide, matrix ## Body ## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN) Chemotherapy damages peripheral nerves through direct toxicity and inflammation. This leads to symptoms like numbness, tingling, burning pain, and reduced sensation, mainly in hands and feet. The damage affects nerve fibers, myelin sheaths, and supporting cells. Repair pathways fall behind degeneration, so symptoms persist after treatment ends. ## Why VIP might help you 1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name. 2. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain. VIP acts on immune and autonomic layers. In rat sciatic nerve injury models, VIP rises after damage and supports remyelination by acting on Schwann cells while lowering pro-inflammatory signals. If your CIPN involves ongoing inflammation around damaged nerves, this pathway could aid tissue-level repair rather than just quieting symptoms. ## Why Gabapentin / pregabalin matters for you **Drug:** Gabapentin / pregabalin **What it does:** Masks neuropathic pain signal; does not repair nerve. **Therefore for you:** This drug suppresses a signal. It can reduce pain perception but does not address the underlying nerve degeneration or support repair pathways in CIPN. Guidelines note limited or no benefit in this specific condition compared with other neuropathies, so any relief trades off against potential side effects without advancing regeneration. ## How these fit together Single-compound focus — VIP targets the immune / autonomic layer of degeneration. Gabapentin / pregabalin addresses symptom signaling only. No direct interaction data exists between them for CIPN. ## What the evidence actually shows No human trials test VIP for CIPN. Preclinical work shows VIP in rat peripheral nerve injury models promotes myelin gene expression in Schwann cells and reduces inflammatory cytokines (preclinical). One rat study measured VIP levels rising during regeneration after sciatic crush. No CIPN-specific rat studies exist. No Reddit or X anecdotes link VIP peptide use to CIPN outcomes. ## What scientists say Research on VIP focuses on general nerve injury repair in animals. Scientists note its potential paracrine effects on remyelination and inflammation resolution after trauma, but emphasize the gap to clinical CIPN application. ## What people say on Reddit No posts describe VIP peptide experiences with chemo neuropathy. Discussions center on standard symptom management or other compounds. ## What people say on X No relevant posts discuss VIP for CIPN. ## What we do not know Whether VIP crosses into meaningful human nerve repair for CIPN remains unknown. Dose, timing, delivery method, and long-term effects lack any data. Interaction with ongoing chemotherapy or gabapentinoids is unstudied. ## Safety and limits VIP research stays at the animal and mechanistic stage for nerve contexts. No established safety profile exists for this use. Any consideration stays experimental. ## Claims (3) - **c1** [human w=0.8] No human trials exist testing VIP for CIPN. - who_claims: grok/grok-4.3 - **c2** [preclinical w=0.5] In rat sciatic nerve injury models VIP supports remyelination and reduces Schwann cell inflammatory cytokines. - who_claims: grok/grok-4.3 - sources: s1 - **c3** [human w=0.8] ASCO guidelines do not recommend gabapentin/pregabalin for CIPN prevention or treatment outside trials. - who_claims: grok/grok-4.3 - sources: s2 ## Voxel graph (3 atoms · 5 edges) - full graph: https://miscsubjects.com/api/articles/vip-chemo-neuropathy/voxels ## Article constitution - full: https://miscsubjects.com/api/articles/constitution ## Source ledger (2) - chain valid: yes · head: `49246ffed8f2e787` ### s1 · pubmed · ok - title: Distinct VIP and PACAP Functions in the Distal Nerve Stump Following Peripheral Nerve Injury - url: https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2019.01326/full - summary: Rat Schwann cell and nerve injury model showing VIP effects on myelin genes and cytokines. - quote: Our results provide evidence that VIP and PACAP could have important functions in the distal nerve stump following injury to promote remyelination and regulate the inflammatory response. - claim_ids: c2 - hash: `db6ffa0c1d42c9ea` ### s2 · review · ok - title: Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy - url: https://www.melbournebreastcancersurgery.com.au/wp-content/themes/ypo-theme/pdf/prevention-and-management-of-2020.pdf - summary: ASCO-aligned guideline summary on CIPN pharmacotherapy limits. - quote: Outside the context of a clinical trial, no recommendations can be made on the use of ... Gabapentin/pregabalin - claim_ids: c3 - hash: `49246ffed8f2e787` ## Provenance (2 model passes) - chain valid: yes · head: `8dda038fe01b72de` - write · grok/grok-4.3 · 2026-06-29T22:34 · hash `592676b2e49e` - voxel_divide · owner · 2026-07-17T02:43 · hash `8dda038fe01b` ## Question graph - questions: 0 · evidence ingests: 0 ## LLM manifest — how to communicate with this ledger - system map: https://miscsubjects.com/api/articles/system-map?format=markdown - topology (ranked): https://miscsubjects.com/api/articles/vip-chemo-neuropathy/topology - ingest: POST https://miscsubjects.com/api/protocol/ingest - claim: POST https://miscsubjects.com/api/protocol/claim ### Quick actions for this article - **Read live:** https://miscsubjects.com/api/articles/vip-chemo-neuropathy/topology - **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"vip-chemo-neuropathy","question":"..."}` - **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest vip-chemo-neuropathy|your evidence` - **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim vip-chemo-neuropathy|tier|assertion` - **iMessage ask:** `vip-chemo-neuropathy|your question` - **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown --- ## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `system_map` — **System map** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **article slug:** `vip-chemo-neuropathy` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **read:** https://miscsubjects.com/api/articles/system-map ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/vip-chemo-neuropathy/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest - **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip - **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip - **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/vip-chemo-neuropathy/bundle?format=markdown - **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.*